Le Lézard
Classified in: Health
Subject: SVY

Global Surgical Drapes Market to Grow at a CAGR of 3.8% by 2021: Driven by a Paradigm Shift Toward Disposable Surgical Drapes


DUBLIN, August 18, 2017 /PRNewswire/ --

The "Global Surgical Drapes Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global surgical drapes market to grow at a CAGR of 3.81% during the period 2017-2021.

Global Surgical Drapes Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


One trend in the market is paradigm shift toward disposable surgical drapes. The use of disposable surgical drapes is gaining popularity due to their several benefits. Disposable surgical drapes offer consistent product quality and reduce the need for sterilization in central sterile processing (CSP). This enables CSP staff to focus on the processing and sterilization of surgical instruments and other supplies. Single-use linens provide a better barrier to limit the transfer of microorganisms.

According to the report, one driver in the market is growing number of surgical procedures in developed countries. Endoscopic surgeries such as colectomies and appendectomies are usually performed laparoscopically. The availability of robotic platforms for complex surgeries such as hysterectomy, hernia repair, and lumpectomy has increased the number of surgeries in the Americas and Europe. To increase patient comfort and reduce the prevalence of HAIs, hospitals and ASCs use surgical drapes, which is driving the growth of the market. According to Eurostat, in 2017, the adoption of MI surgeries increased the demand of surgical drapes in Europe, due to the increase of laparoscopic procedures.

Further, the report states that one challenge in the market is lower profit margins and increasing pricing pressure. The global surgical drapes market is highly fragmented due to the presence of several vendors that have significant market shares. The leading vendors have broad product portfolios of advanced high-end surgical drapes, which are disposable and reusable. Small and medium-sized companies focus on a single product line in a specific geographic region. Hence, the leading vendors are facing lower profit margins due to competition. The vendors are also experiencing severe pricing pressure, which has resulted in price wars.

Key Vendors

Other Prominent Vendors

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Segmentation by usability

PART 07: Segmentation by end-user

PART 08: Segmentation by geography

PART 09: Decision framework

PART 10: Drivers and challenges

PART 11: Market trends

PART 12: Vendor landscape

PART 13: Key vendor analysis

For more information about this report visit https://www.researchandmarkets.com/research/ztgb7k/global_surgical

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: